Therefore, identification of compounds that exhibit TTR fertilization inhibitory or TTR amyloid fibril disrupting activities might be potential candidates for the development of therapeutic agents in TTR amyloidosis. This evidence concerns the gene TTR and familial amyloid neuropathy.